Replies to post #300184 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Ex, the point is not about patient selection bias whether positive or negative but to back that up with proper references which she clearly didn't.

And again, she had the proper references. The CLDX reference specifically states it. Selecting EGFRvIII+ is a bias. The NWBO does not specifically state it, but suggests it could be the case based on the total % excluded..